| Revenues | | 13,203.00 | 14,366.00 | 13,467.00 | 12,651.00 |
| | 951.00 | - | - | - |
| Research and Development | | 951.00 | - | - | - |
| Costs And Expenses | | 11,280.00 | 12,592.00 | 12,354.00 | 11,201.00 |
| Operating Income/Loss | | 1,923.00 | 1,774.00 | 1,113.00 | 1,450.00 |
| Income/Loss From Equity Method Investments | | -20.00 | -14.00 | -14.00 | -12.00 |
| Income/Loss From Continuing Operations Before Tax | | 496.00 | 291.00 | 2,620.00 | 1,504.00 |
| Income Tax Expense/Benefit, Deferred | | 106.00 | -287.00 | -4,167.00 | 87.00 |
| Income Tax Expense/Benefit | | 194.00 | -40.00 | -4,046.00 | 142.00 |
| | 282.00 | 317.00 | 6,652.00 | 1,350.00 |
| Attributable To Parent | | 263.00 | 296.00 | 6,626.00 | 1,355.00 |
| Available To Common Stockholders, Basic | | 263.00 | 296.00 | 6,626.00 | 1,355.00 |
| Attributable To Noncontrolling Interest | | 19.00 | 21.00 | 26.00 | -5.00 |
| Basic Average Shares | | 2,052.19 | -3.97 | 2,084.18 | 2,091.11 |
| Diluted Average Shares | | 2,071.39 | -4.60 | 2,124.39 | 2,125.63 |
| Basic Earnings Per Share | | 0.13 | 0.15 | 3.18 | 0.65 |
| Diluted Earnings Per Share | | 0.13 | 0.16 | 3.11 | 0.63 |